Table 1.

Demographic and clinical characteristics at baseline. P values denote the significance of differences between groups calculated by the Mann-Whitney U test if continuous and by the chi-square test if proportions. Values are mean (SD) unless otherwise specified.

VariablesMissing, nAllWomenMen
Cohort 1Cohort 2pCohort 1Cohort 2pCohort 1Cohort 2p
n9281010632706296304
Age, yrs053 (14)56 (15)< 0.00152 (14)55 (15)< 0.00157 (13)58 (14)0.235
Disease duration, mos06.3 (3.1)5.9 (3.1)0.0046.4 (3.1)6.0 (3.1)0.0055.9 (3.0)5.7 (3.1)0.315
Never smoker, %443850430.01230260.183
Smoker, %727250.00526263026
Previous smoker, %293624314048
RF-positive, %3360630.24158640.03165620.272
HAQ, 0–31190.95 (0.60)1.02 (0.63)0.0121.02 (0.60)1.08 (0.64)0.0710.79 (0.56)0.88 (0.60)0.065
DAS28, 0–9.4575.16 (1.21)5.35 (1.22)0.0015.24 (1.17)5.38 (1.23)0.0324.99 (1.29)5.26 (1.20)0.009
VAS pain, 0–100 mm4844.8 (24.3)48.5 (24.1)0.00146.1 (24.2)50.0 (23.8)0.00441.9 (24.4)44.9 (24.5)0.134
PtGA, 0–100 mm3644.5 (25.5)47.5 (25.8)0.00345.7 (25.9)49.0 (25.5)0.02040.4 (24.4)44.0 (26.2)0.087
SHS3432.9 (7.1)4.9 (9.1)< 0.0012.7 (6.4)5.0 (9.4)< 0.0013.3 (8.5)4.5 (8.3)0.084
JSN3432.1 (4.8)4.2 (7.4)< 0.0012.0 (4.6)4.4 (7.7)< 0.0012.2 (5.2)3.6 (6.7)0.008
ES3431.6 (4.0)1.4 (3.2)0.2481.4 (3.4)1.4 (3.3)0.9362.1 (5.0)1.5 (3.2)0.109
  • Significant data are in bold face. RF: rheumatoid factor; HAQ: Health Assessment Questionnaire; DAS28: 28-joint Disease Activity Score; VAS: visual analog scale; PtGA: patient’s global assessment; SHS: van der Heijde modification of the Sharp score; JSN: joint space narrowing; ES: erosion score.